For full functionality of this publication it is necessary to enable Javascript.

Click here to see instructions how to enable JavaScript in your web browser.

<--
Medical Editors

Michael K Brawer, MD

Dr. Brawer is Chief Executive Officer of URIDEA in Seattle, WA, and formerly Professor of Urology and Adjunct Professor, Department of Pathology, at the University of Washington. A frequent principal investigator in benign and neoplastic proliferative disorders, he cofounded Reviews in Urology, serves on the boards of 12 other journals, and has published more than 300 articles, books, and abstracts.

Herbert Lepor, MD

Known for his pioneering work in the surgical management of prostate cancer and the physiology and pharmacology of benign prostatic disorders, Dr. Lepor is cofounder of Reviews in Urology. He is Professor and Martin Spatz Chairperson of Urology and Professor of Pharmacology at New York University School of Medicine in New York, NY.
Contributing Editors

Dean G Assimos, MD

An internationally recognized leader in all aspects of managing patients with nephrolithiasis, Dr. Assimos is Chair, Department of Urology at the University of Alabama at Birmingham School of Medicine. He is a member of the American Urological Association Nephrolithiasis Guidelines Committee and is currently conducting clinical and basic science research on oxalate metabolism.

Arie S Belldegrun, MD, FACS

A leading urologic oncologist with expertise in drug development and clinical trials, immunotherapy, and targeted therapy for genitourinary cancers, Dr. Belldegrun is the Director of the Institute of Urologic Oncology at University of California, Los Angeles (UCLA), Professor and Chief of Urologic Oncology, the Doumani Chair in Urologic Oncology at The David ­Geffen School of Medicine at UCLA in Los Angeles, CA.

Benjamin M Brucker, MD

A recognized expert in female pelvic medicine and reconstructive surgery, urodynamics, incontinence, and voiding dysfunction in men and women, Dr. Brucker has authored numerous peer-reviewed articles and book chapters on these subjects, and was an associate editor of Vaginal Surgery for the Urologist. Dr. Brucker is an Associate Professor of Urology at New York University Langone Medical Center, where he serves as the Director Neurourology at the Multiple Sclerosis Comprehensive Care Center.

Michael B Chancellor, MD

Michael B. Chancellor, MD, is Professor of Urology and Director of Neurourology ­Program in the Department of Urology at the Oakland University William Beaumont School of Medicine in Royal Oak, MI. Dr. Chancellor has written more than 600 book ­chapters and peer-reviewed articles in journals including the Journal of Urology, Urology, Gene Therapy, and The Lancet. He has also written 11 books and serves on the editorial board of 12 scientific journals. Dr. Chancellor has gained national and international recognition in the areas of stem cell and tissue engineering and drug discovery. He was the first urologist to use botulinum toxin to treat lower urinary tract dysfunction.

Bob Djavan, MD, PhD

An expert in the management of prostate cancer, urologic oncology, benign prostatic hyperplasia, and treatment options, Dr. Djavan is Professor and Director of the Minimally Invasive and Prostate Translational Center in the Department of Urology at New York University School of Medicine. He is also on the board of the European School of Urology,on the directing board of the European Society of Urooncology, and part of the European Board of Urology examination committee

Steven A Kaplan, MD

Kaplan is E Darracott Vaughan Jr Professor of Urology and Director, Iris Cantor Men’s Health Center at Weill Cornell Medical College of Cornell University in New York, NY. Dr. Kaplan is on the editorial boards of Urology and the Journal of Urology, and has authored more than 700 articles.

Stacy Loeb, MD

An expert in prostate cancer epidemiology and outcomes research, Dr. Loeb is a graduate of the Johns Hopkins urology residency program and a Clinical Instructor in the Department of Urology at New York University. She has authored more than 140 peer-reviewed publications and numerous book chapters related to prostate cancer. Dr. Loeb has several international research collaborations and also serves on the Editorial Board of BJU International.

Randall B Meacham, MD

An authority on male reproductive medicine and surgery, Dr. Meacham is program director of the Rocky Mountain Urological Society. He also serves as co-moderator of Androlog, an internet-based group for clinicians and scientists involved in the diagnosis and treatment of male infertility. Dr. Meacham is Professor, Residency Program Director, and Head of the Division of Urology at the University of Colorado School of Medicine in Denver, CO.

J Curtis Nickel, MD, FRCSC

A respected researcher in the fields of inflammatory diseases of the urinary tract and benign diseases of the prostate, Dr. Nickel is Professor of Urology at Queen’s University in Kingston, Ontario, Canada, and Canadian Institutes of Health Research (CIHR) Canada Research Chair in Urologic Pain and Inflammation. He directs the Prostatitis and Interstitial Cystitis Clinical Research Center and BPH Clinical Research at the Centre for Applied Urological Research, Kingston.

Alan W Partin, MD, PhD

A prominent researcher on benign prostatic hyperplasia and prostate cancer, with a current focus on new prostate cancer serum markers, Dr. Partin is the David Hall McConnell Professor and Director of Urology at The Johns Hopkins Medical Institutions and The Johns Hopkins Hospital in Baltimore, MD. He is also the editor of Campbell-Walsh Urology.

Jacob Rajfer, MD

Recognized for his work in the areas of male infertility and erectile dysfunction, Dr. Rajfer is Professor of Urology in the Department of Urology at the University of California at Los Angeles. He is also Chief of Urology at Harbor-UCLA Medical Center in Torrance, CA.

Claus G Roehrborn, MD, FACS

A clinician and researcher recognized for his contributions to the study of benign and malignant prostate diseases, Dr. Roehrborn is Professor and Chairman of the Department of Urology at The University of Texas Southwestern Medical Center at Dallas. He is on multiple editorial boards, is Associate Editor of Urology, and author of more than 300 peer-reviewed publications, mostly in the field of prostatic diseases.

Ellen Shapiro, MD, FACS, FAAP

Professor and Director of Pediatric Urology at New York University School of Medicine, Dr. Shapiro is known for her contributions to pediatric urology, especially in the area of fetal bladder, prostate, and urethral development. She recently served on the American Urological Association Guideline Panel for Vesicoureteral Reflux.

Kevin M Slawin, MD

With a combined focus on prostate disease research and treatment, Dr. Slawin is founder and Director of the Vanguard Urologic Institute and the Texas Prostate Center in Houston, TX. He is a member of the Center for Clinical and Translational Sciences at the University of Texas Health Science Center at Houston, Clinical Professor of Urology at Baylor College of Medicine, and Director of Urology at Memorial Hermann Hospital, Texas Medical Center.

David Sussman, DO, FACOS

In addition to general urology, Dr. Sussman’s specific areas of expertise include female urology and voiding dysfunction and large group socioeconomic issues. Dr. Sussman is a clinical associate professor of the Department of Surgery, Division of Urology at the University of Medicine and Dentistry of New Jersey and has served as past Chief of Staff at Kennedy Health System. He is Head of Urology at Kennedy Health System, Washington Township Campus. Dr. Sussman is Past President of the urology section of the American College of Osteopathic Surgeons and Section Head of Female Urology.